Prednisone and Chronic graft versus host disease - a phase IV clinical study of FDA data

Summary:

Chronic graft versus host disease is found among people who take Prednisone, especially for people who are male, 10-19 old.

The phase IV clinical study analyzes which people take Prednisone and have Chronic graft versus host disease. It is created by eHealthMe based on reports of 523,651 people who have side effects when taking Prednisone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

523,651 people reported to have side effects when taking Prednisone.
Among them, 315 people (0.06%) have Chronic graft versus host disease.

What is Prednisone?

Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. eHealthMe is studying from 531,346 Prednisone users for its effectiveness, alternative drugs and more.

What is Chronic graft versus host disease?

Chronic graft versus host disease (immune cells attack the host's body cells after transplant) is found to be associated with 463 drugs and 269 conditions by eHealthMe.

Number of Prednisone and Chronic graft versus host disease reports submitted per year:

Could Prednisone cause Chronic graft versus host disease?

Gender of people who have Chronic graft versus host disease when taking Prednisone*:

Click here to view

Age of people who have Chronic graft versus host disease when taking Prednisone *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Prednisone and have Chronic graft versus host disease?

Check whether Chronic graft versus host disease is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Chronic graft versus host disease and when was it recovered:

Chronic graft versus host disease in Prednisone

Expand to all the drugs that have ingredients of prednisone:

Chronic graft versus host disease and drugs with ingredients of prednisone

Alternative drugs to, pros and cons of Prednisone:

Prednisone (531,346 reports)

Common Prednisone side effects:

Drug ineffective: 66,683 reports
Fatigue (feeling of tiredness): 46,071 reports
Pain: 44,380 reports
Breathing difficulty: 39,929 reports
Joint pain: 38,003 reports
Diarrhea: 32,985 reports
Rashes (redness): 31,608 reports

Browse all side effects of Prednisone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Chronic graft versus host disease treatments and more:

Chronic graft versus host disease (5,639 reports)

COVID vaccines that are related to Chronic graft versus host disease:

Common drugs associated with Chronic graft versus host disease:

All the drugs that are associated with Chronic graft versus host disease:

Chronic graft versus host disease (463 drugs)

Common conditions associated with Chronic graft versus host disease:

Preventive health care: 169 reports

All the conditions that are associated with Chronic graft versus host disease:

Chronic graft versus host disease (269 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on prednisone (the active ingredients of Prednisone) and Prednisone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.